Search results
Why Do I Have Itchy Feet During Pregnancy?
Parents via Yahoo News· 6 days agoAlthough people often find that pregnancy offers relief from itchy psoriasis symptoms, for about 10% to 20% of pregnant people, pregnancy makes psoriasis
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 6 days agoThe Law Offices of Frank R. Cruz reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Ventyx ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 3 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 5 days agoA decision on approval is expected in the fourth quarter of 2024.
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 3 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie traded as low as $158.56 and last ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports. Barclays‘s ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 2 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Amgen (AMGN) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 5 days agoAmgen (NASDAQ:AMGN – Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $3.82 per share ...
